Testing a new aortic heart valve in India
Part of Heart & circulation clinical trials.
This trial tests a new type of aortic heart valve (PoliaValve) for people with severe aortic valve disease who need valve replacement surgery. If you qualify, you will receive the experimental valve and be followed for one year to see how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years old or older
- You have severe symptoms from a narrowed or leaky aortic valve (like chest pain, shortness of breath, or fainting)
- You have not had heart valve surgery before
- You don't need emergency heart surgery
- You are willing and able to come to all follow-up visits for one year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of artificial heart valve made of polymer (a special plastic-like material) for people with severe aortic valve disease. It aims to see if the valve is safe and works well, giving you an option for a replacement valve that might last longer.
This trial tests a new polymer heart valve for people with severe aortic valve narrowing or leakage. It aims to see if the valve is safe and works well as a replacement.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
This trial studies Prizvalve Pro™, a new transcatheter (catheter-based) aortic valve replacement, for people with severe aortic valve narrowing who are too high-risk for standard surgery. It may help your heart work better and improve symptoms by replacing the failing valve without open-heart surgery.
This study tests a new type of prosthetic heart valve made from a special polymer material. It is for adults who need surgical replacement of either the mitral or aortic valve.
This trial tests a new device to treat a leaking aortic valve in people who already have a left ventricular assist device (LVAD). The goal is to fix the leak without open-heart surgery, which may improve how well the LVAD works and reduce symptoms.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.